The plant-based protein company Beyond Meat faces escalating turmoil as new legal pressures emerge. This Thursday, multiple law firms initiated class action lawsuits alleging potential securities fraud. Shareholders are accusing the company of making misleading statements concerning asset valuations, a development that arrives as the stock price languishes deep in penny-stock territory.
Shareholder Lawsuits Allege Misrepresentation
Legal actions filed by Portnoy Law Firm and Bernstein Liebhard LLP seek to represent investors who suffered losses. The suits focus on shareholders who purchased Beyond Meat equity between February and November 2025. The allegations are substantial: company leadership is accused of issuing false statements regarding the true value of long-term assets and concealing necessary write-downs.
Court documents suggest the carrying value of certain assets was inflated above their fair market value, information that was not disclosed to the market. Consequently, investors were allegedly unable to foresee the risk of a significant non-cash impairment charge and the related difficulties in filing financial statements on time.
A Stock in Distress
These legal entanglements plague a company whose market standing has deteriorated sharply. Closing at $0.71 on Wednesday, the share price has collapsed approximately 81% over the past twelve months. The firm’s total market capitalization has shrunk to a range between $320 million and $340 million.
Should investors sell immediately? Or is it worth buying Beyond Meat?
A fleeting rally in Q4 2025, which saw a short squeeze temporarily propel the stock 350% higher, was deemed unsustainable by market observers. In a recent client note, the investment firm Deep Sail Capital characterized this surge as nothing more than a “special situation.”
Sequence of a Decline
The legal complaints reference a chain of negative revelations in late 2025 that shattered market confidence:
- The Initial Warning: In late October, Beyond Meat cautioned investors of substantial impending write-downs for its third quarter, triggering an immediate single-day share price drop exceeding 23%.
- The Filing Delay: Early November brought an announcement that the quarterly report would be postponed to allow for a more thorough review of the company’s books, a move that pushed the stock down an additional 16%.
- The Results: On November 10, the corporation finally reported an operating loss of $112.3 million. This figure included a $77.4 million impairment charge related to property, plant, equipment, and leasehold improvements.
For current shareholders, the litigation represents a further burden during a critically challenging period. Management must now navigate a dual challenge: addressing the core operational issues that necessitated the major write-downs while simultaneously mounting a defense against the lawsuits. The next key date in this legal proceeding is March 24, 2026, which serves as the deadline for investors to apply as lead plaintiff.
Ad
Beyond Meat Stock: Buy or Sell?! New Beyond Meat Analysis from February 5 delivers the answer:
The latest Beyond Meat figures speak for themselves: Urgent action needed for Beyond Meat investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 5.
Beyond Meat: Buy or sell? Read more here...
